Literature DB >> 17017893

Phenothiazine: the parent molecule.

S C Mitchell1.   

Abstract

Phenothiazine is an aromatic tricyclic compound that first emerged from the furtive chemical activity surrounding the aniline dye industry at the latter half of the 19th century. It contains both nitrogen and sulphur atoms and is the parent molecule of a multitude of drugs that have enjoyed varied and extensive use throughout medical and veterinary practice. The compound itself is not without biological activity and has been shown to possess insecticidal, antifungal, antibacterial and anthelmintic properties. It was this latter vermifugal application that has earned the molecule a place alongside penicillin and DDT for its colossal impact on mankind. Following its extensive usage over many years, unwanted reactions including neuromuscular incoordination, photosensitization and haemolytic anaemia have been reported and these have limited its use in the present climate. Investigations into the mode of action of phenothiazine and its underlying biochemical properties have been undertaken but the molecule has yet to reveal its secrets and still poses problems of understanding at the molecular level. This article reviews the literature, both established and current, and presents a contemporary view on phenothiazine and its interaction with biological systems.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17017893     DOI: 10.2174/138945006778226552

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  6 in total

1.  A novel and specific NADPH oxidase-1 (Nox1) small-molecule inhibitor blocks the formation of functional invadopodia in human colon cancer cells.

Authors:  Davide Gianni; Nicolas Taulet; Hui Zhang; Celine DerMardirossian; Jeremy Kister; Luis Martinez; William R Roush; Steven J Brown; Gary M Bokoch; Hugh Rosen
Journal:  ACS Chem Biol       Date:  2010-10-15       Impact factor: 5.100

2.  SPECTROSCOPIC AND ELECTROCHEMICAL PROPERTIES OF 2-AMINOPHENOTHIAZINE.

Authors:  Luis Piñero; Xiomara Calderón; Juan Rodríguez; Ileana Nieves; Rafael Arce; Carmelo García; Rolando Oyola
Journal:  J Photochem Photobiol A Chem       Date:  2008-07-05       Impact factor: 4.291

Review 3.  NOX1, 2, 4, 5: counting out oxidative stress.

Authors:  K Wingler; J J R Hermans; P Schiffers; Al Moens; M Paul; H H H W Schmidt
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

4.  Synthesis, spectroscopic characterization, and anticancer activity of new 10-substituted 1,6-diazaphenothiazines.

Authors:  Beata Morak-Młodawska; Krystian Pluta; Małgorzata Latocha; Małgorzata Jeleń
Journal:  Med Chem Res       Date:  2016-08-04       Impact factor: 1.965

5.  Design, Synthesis, and Structural Characterization of Novel Diazaphenothiazines with 1,2,3-Triazole Substituents as Promising Antiproliferative Agents.

Authors:  Beata Morak-Młodawska; Krystian Pluta; Małgorzata Latocha; Małgorzata Jeleń; Dariusz Kuśmierz
Journal:  Molecules       Date:  2019-11-30       Impact factor: 4.411

6.  Polymyxin B combinations with FDA-approved non-antibiotic phenothiazine drugs targeting multi-drug resistance of Gram-negative pathogens.

Authors:  Maytham Hussein; Xiaohan Hu; Olivia K A Paulin; Simon Crawford; Qi Tony Zhou; Mark Baker; Elena K Schneider-Futschik; Yan Zhu; Jian Li; Tony Velkov
Journal:  Comput Struct Biotechnol J       Date:  2020-08-21       Impact factor: 7.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.